Effectiveness and safety of rivaroxaban versus warfarin in patients with nonvalvular atrial fibrillation and heart failure

被引：0
|
作者：
Coleman, C. I. [1 ]
Baker, W. L. [1 ]
Bunz, T. J. [2 ]
Eriksson, D. [3 ]
Meinecke, A. K. [3 ]
Sood, N. A. [4 ]
机构：
[1] Univ Connecticut, Pharm Practice, Storrs, CT USA
[2] New England Hlth Analyt LLC, Pharmacoepidemiol, Granby, CO USA
[3] Bayer AG, Berlin, Germany
[4] Southcoast Hlth Syst, Cardiac Electrophysiol, Fall River, MA USA
来源：
EUROPEAN HEART JOURNAL | 2018年 / 39卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P4813
引用
收藏
页码：1012 / 1012
页数：1
相关论文
共 50 条
  • [11] Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
    Patel, Manesh R.
    Mahaffey, Kenneth W.
    Garg, Jyotsna
    Pan, Guohua
    Singer, Daniel E.
    Hacke, Werner
    Breithardt, Guenter
    Halperin, Jonathan L.
    Hankey, Graeme J.
    Piccini, Jonathan P.
    Becker, Richard C.
    Nessel, Christopher C.
    Paolini, John F.
    Berkowitz, Scott D.
    Fox, Keith A. A.
    Califf, Robert M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (10): : 883 - 891
  • [12] Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
    Pearson, Scott
    Troughton, Richard
    Richards, A. Mark
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (24): : 2334 - 2335
  • [13] Effectiveness and Safety of Rivaroxaban Versus Warfarin among Nonvalvular Atrial Fibrillation Patients with Concomitant Obstructive Sleep Apnea
    Sood, Nitesh
    Ashton, Veronica
    Bessada, Youssef
    Galli, Katelyn
    Bookhart, Brahim K.
    Coleman, Craig I.
    TH OPEN, 2023, 07 (01) : e82 - e93
  • [14] Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation REPLY
    Patel, Manesh R.
    Fox, Keith A. A.
    Califf, Robert M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (24): : 2335 - 2335
  • [15] RIVAROXABAN VERSUS WARFARIN IN AFRICAN AMERICAN PATIENTS WITH NONVALVULAR ATRIAL FIBRILLATION
    Coleman, Craig I.
    Thompson, Stanley
    Ashton, Veronica
    Palladino, Michael
    Bunz, Thomas
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (11) : 338 - 338
  • [16] REAL-WORLD COMPARATIVE EFFECTIVENESS AND SAFETY OF RIVAROXABAN AND WARFARIN IN NONVALVULAR ATRIAL FIBRILLATION PATIENTS
    Laliberte, F.
    Cloutier, M.
    Nelson, W. W.
    Coleman, C., I
    Pilon, D.
    Olson, W. H.
    Damaraju, C., V
    Schein, J. R.
    Lefebvre, P.
    VALUE IN HEALTH, 2014, 17 (03) : A102 - A103
  • [17] Real-World Comparative Effectiveness and Safety of Rivaroxaban and Warfarin in Nonvalvular Atrial Fibrillation Patients
    Laliberte, Francois
    Cloutier, Michel
    Nelson, Winnie W.
    Coleman, Craig I.
    Duh, Mei Sheng
    Pilon, Dominic
    Damaraju, C. V.
    Schein, Jeffrey R.
    Lefebvre, Patrick
    CIRCULATION, 2013, 128 (22)
  • [18] Real-world comparative effectiveness and safety of rivaroxaban and warfarin in nonvalvular atrial fibrillation patients
    Laliberte, Francois
    Cloutier, Michel
    Nelson, Winnie W.
    Coleman, Craig I.
    Pilon, Dominic
    Olson, William H.
    Damaraju, C. V.
    Schein, Jeffrey R.
    Lefebvre, Patrick
    CURRENT MEDICAL RESEARCH AND OPINION, 2014, 30 (07) : 1317 - 1325
  • [19] Rivaroxaban Versus Warfarin in African American Patients with Nonvalvular Atrial Fibrillation
    Coleman, Craig, I
    Thompson, Stanley
    Ashton, Veronica
    Palladino, Michael
    Bunz, Thomas J.
    JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION, 2020, 112 (04) : 395 - 401
  • [20] Polypharmacy and the Efficacy and Safety of Rivaroxaban Versus Warfarin in the Prevention of Stroke in Patients With Nonvalvular Atrial Fibrillation
    Piccini, Jonathan P.
    Hellkamp, Anne S.
    Washam, Jeffrey B.
    Becker, Richard C.
    Breithardt, Guenter
    Berkowitz, Scott D.
    Halperin, Jonathan L.
    Hankey, Graeme J.
    Hacke, Werner
    Mahaffey, Kenneth W.
    Nessel, Christopher C.
    Singer, Daniel E.
    Fox, Keith A. A.
    Patel, Manesh R.
    CIRCULATION, 2016, 133 (04) : 352 - 360
12345